Get started

Investment

$DOGE.X PT 15 and higher next$DOGE.X to the Moon SpaceX will basically mine Iridium Iridium is needed for EV batteries The average annual price for iridium in 2020 was 2,550 U.S. dollars per troy ounce. The price of iridium dramatically increased in March 2021, to 6,000 U.S. dollars per troy ounce as a result of supply shortages combined with its prospective use to produce green hydrogen. Iridium is a transition metal and a platinum group metal. It is one of the most corrosion-resistant metals and is also one of the rarest elements in the Earth's crust.
by BADQOMOCAWGOWLD
4
$VXRT entry Target PTs 7.20-8-8.20 Long term PTs 75-200-500$VXRT entry Target PTs 7.20-8-8.20 Long term PTs 75-200-500 and higher...timeline Sept 2022 Wyckoff Re-accumulation after decline Catalyst: Shares of Vaxart (Nasdaq: VXRT) rose on Monday after the biotech said the U.S. Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for its oral Coronavirus vaccine. Why Vaxart Stock Surged Today The vaccine maker has a promising new construct for its experimental COVID-19 tablet. What happened Shares of Vaxart (Nasdaq: VXRT) rose on Monday after the biotech said the U.S. Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for its oral coronavirus vaccine. As of 2:20 p.m. EDT, Vaxart's stock price was up more than 12%. So what Vaxart's S-only vaccine construct produced higher serum antibodies than its other vaccine candidate, which expresses both S and N proteins, in a non-human primate study. Vaxart plans to begin a phase II clinical trial for its S-only vaccine later this year. "This new clinical trial will allow us to compare the S-only and S+N vaccine candidates and put us in a position to decide which approach offers the best way forward for our COVID-19 vaccine development program, particularly in the face of emerging variant strains," Vaxart's chief scientific officer Dr. Sean Tucker said in a press release. Now what If Vaxart's new vaccine construct can produce a stronger antibody response in human patients than its other oral vaccine did in prior studies, it could become a more legitimate competitor to the COVID-19 drugs developed by Pfizer and Moderna. As a tablet, Vaxart's oral vaccine would be easier to store, transfer, and administer. If Vaxart can demonstrate a comparable efficacy and safety profile to the leading vaccines currently on the market, there would likely be tremendous demand for its new drug. This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.
NASDAQ:VXRTLong
by BADQOMOCAWGOWLD
2
$CLDX PT 400 and higherCelldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity; CDX-1140, a human agonist monoclonal antibody targeted to CD40, a key activator of immune response, which is found on dendritic cells, macrophages, and B cells, as well as is expressed on various cancer cells; and CDX-527, a bispecific antibody, which uses the company's proprietary active anti-PD-L1 and CD27 human antibodies to couple CD27 costimulation with blockade of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses through CD27 costimulation. Celldex Therapeutics, Inc. has research collaboration and license agreements with University of Southampton to develop human antibodies towards CD27; Amgen Inc. with exclusive rights to CDX-301 and CD40 ligand; and Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.
NASDAQ:CLDXLong
by BADQOMOCAWGOWLD
BTC/USDIn case the bulls can close the weekly bar above 38.4k, there would be a decent chance to see 42k again this weeks. I'm looking at the current major support as a good entry point this period for BTC , only to resume the bullish move after that. In a period of days BTC is currently +11.92% increase in value without any correction in between. and this is very healthy for the trend 🚀. -Use risk management and be ready for all scenarios -Don't forget likes and follow for more ideas and signals -Best of wishes ❤️
Long
by DeclanBrock
10
LINK/USD: Chainlink to way to $100 USDI believe that the montly timeframe it's look extremely interesting for who thinking to buy Chainlink in $15 USD. Chainlink it's became more cheap when the higher price was at $50 USD. Now, I believe that Chainlink support this key support line that it's a way that Chainlink going to the way to $100 USD. And also, I believe that Chainlink like investiment it's look interesting to invest, but I believe that Chainlink never will overtake Cardano in this rally, becuase Cardano it's a giant cryptocurrency more powerful than Chainlink. For that, right now, I'm enfocous in 3 specific cryptocurrencies: Ethereum, Cardano and XRP. For that, I have my own plan using this cryptocurrencies. Ethereum, Cardano and XRP are the biggest cryptocurrency that I know wth a lot potential of their adoption and very competitive. But maybe, I consider to buy Chainlnk spot in my broker to invest in the trading by swing trading until $100 USD if I bought in $15 USD.
BINANCE:LINKUSDLong
by harisonhbn9718
3
ETH/USD: Ethereum need to hold $1,900 USD to continue upLooking in 3 Daily timeframe. Ethereum continue fight to break down the key support of $1,900 USD. But, if you look my recently analsyis that Ethereum show us a bullish divergence, I hope a bull cases continue to fight. That it's my perspective in Ethereum that based in this model, Ethereum could to hit the mark of $5,000 USD in medium term when Ethereum get more power to continue up in this bull rally. For that, some altcoins are up in front of Ethereum, but Ethereum it's a monster cryptocurrency and mother who dominate the altcoins. s3.tradingview.com I'm in this trade that we could to view in Daily timeframe.
COINBASE:ETHUSDLong
by harisonhbn9718
12
A Success Tunnel for 360 DigiTech: Business TransformationChina's outstanding loan balance reached a fresh record of CNY 172.75 trillion in 2020 and keeps growing, spurred by the increasing digitalization and booming e-commerce market. In China, 2020 was a milestone year for fintech. The year saw heightened regulatory scrutiny, intensified competition and business patterns were altered by the COVID-19 outbreak, both in the corporate and consumer sectors. The Matthew effect in the industry has been further exacerbated under such circumstances, where small-sized companies with less capital or poor risk resistance ability will be forced to quit the stage. Although 360 DigiTech, Inc. (QFIN:NASDAQ) is a late starter, it is one of those niche players able to stand up to this fierce competition, mainly due to the reputation of its parent company – 360 Security Technology, Inc. (601360:SH) which brings significant brand visibility to the table. Strong performance with low valuation This USD 6.57 billion company is currently outperforming what the market expects. On May 27, 360 DigiTech released its unaudited financial results for the first quarter of 2021. The total net revenue increased by 13.1% to CNY 3.6 billion (USD 0.55 billion) from CNY 3.2 billion in the same period of 2020, while the non-GAAP net income reached CNY 1.41 billion (USD 0.2 billion) with an astonishing increase of 452.8%. The operating income along with the account under the non-GAAP measure achieved a growth of 745.7% and 533.0%, respectively. However, given this relatively strong financial performance, 360 DigiTech's P/E ratio appears to have been lower than that of its peers for a long time, although it is currently ranked the highest among the top four. Lexin (LX:NASDAQ), a leading online consumption and consumer finance platform, is also using technologies to encompass risk management and loan facilitation systems, just as QFIN does, but its P/E ratio is far higher than that of QFIN. For example, in the third quarter of 2020, Lexin's P/E ratio was more than 5 times that of 360 DigiTech; by Q2 2021, Lexin was lower than 360 DigiTech for the first time, at the level of 8.1. Along with the progressively upward stock price, the necessity of re-assessing 360 DigiTech is becoming more obvious. How the asset-light business model works 360 DigiTech is one of the earliest platforms in the industry to proactively initiate the transformation of reducing the proportion of self-operated loans and improving loan facilitation. This turned out to be an informed decision. In the third quarter of 2019, 360 DigiTech first proposed its new strategic target for adopting the 'capital-light,' or more commonly as 'asset-light' business model. More colloquially, this refers to the company directly navigating the borrower to their cooperative financial institution, while collecting service fees from credit evaluation, credit management, or other technical-related services. According to the published unaudited financial results of 360 DigiTech for the first quarter of 2021, the total loans originated by financial institutions were CNY 74.15 billion, of which CNY 37.25 billion (50.2%) was under an asset-light model and other technology solutions, achieving an astonishing increase of 211.9% over the same period in 2020. Haisheng Wu, CEO of 360 DigiTech, stated that "...over 50% of the loans were facilitated under the capital-light model and other technology solutions..." and it is a "fundamental change to the nature of our business, from being capital-driven to technology-driven." The highlight of this model is that as a loan facilitator, the company is not required to inject any margin for each loan. In other words, the credit risk of the asset-light business is borne by the capital; the loan facilitator is thus riskless. Besides, it can better respond to regulatory requirements and resist the impacts of uncertainty on business stability. Moving further towards 'tech' In policy terms, the tightening regulatory rules pose a little impact to loan facilitators like 360 DigiTech – even as fintech giants like Ant Group and JD Digits may suffer – as its targets are excess leverage and systematic risks. It creates opportunities for 360 DigiTech to jump a queue. The asset-light model is hence the core strategy of reducing the regulatory and credit risk. Besides, QFIN is trying to use less capital and more technology-powered services to open up more opportunities, both in terms of client acquisition and risk management. The improved portfolio quality, as indicated by the relatively low delinquency ratio, was one of the contributors for its shining performance even in the special 2020, although it showed an upward-trending slope for the period during the epidemic. However, it seems reasonable: due to the lag of loan repayment as well as its timeliness of statistics, the negative effects of China's -6.8% GDP in 2020Q1 only started to appear in the second quarter of 2020, causing a history of high non-payment ratio of 2.82%. Up to date, the company's delinquency ratio has nearly risen back to the level before COVID-19, and we will keep an eye on its future performance. Moreover, with a few innovations and technologies, for example, Argus RM Model, Intelligence Credit Engine (ICE), Cloud Bank System, Cosmic Cube System, Apollo Platform and AI Robots, 360 DigiTech is working hard towards the 'tech side' of the fintech business as well as being technology partners with banks. The strategic collaboration with Kincheng Bank (KCB) is a good example. The bottom line 360 DigiTech's asset-light model works well, and it has the potential to pay off from the long-term perspective, which brings further expectation for its growth prospects. The company's business expansion plans are proceeding with KCB as the first step. These strategies will further improve the company's flexibility in this competition for market share. Fo rthe full article with chart, please visit the original link
NASDAQ:QFINLong
by EqualOcean